MTM Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$608K Sell
2,394
-14
-0.6% -$3.26K 0.26% 52
2026
Q1
$589K Buy
2,408
+36
+2% +$8.38K 0.28% 48
2025
Q4
$491K Hold
2,372
0.23% 54
2025
Q3
$440K Hold
2,372
0.22% 55
2025
Q2
$362K Sell
2,372
-1
-0% -$154 0.2% 55
2025
Q1
$394K Sell
2,373
-158
-6% -$24.7K 0.23% 55
2024
Q4
$366K Hold
2,531
0.22% 55
2024
Q3
$410K Hold
2,531
0.25% 50
2024
Q2
$370K Hold
2,531
0.24% 49
2024
Q1
$400K Sell
2,531
-44
-2% -$7K 0.27% 44
2023
Q4
$404K Hold
2,575
0.29% 36
2023
Q3
$401K Hold
2,575
0.33% 33
2023
Q2
$426K Hold
2,575
0.36% 33
2023
Q1
$399K Sell
2,575
-70
-3% -$11.3K 0.35% 33
2022
Q4
$467K Hold
2,645
0.41% 32
2022
Q3
$432K Hold
2,645
0.39% 33
2022
Q2
$470K Hold
2,645
0.41% 33
2022
Q1
$469K Buy
+2,645
New +$450K 0.49% 31

Other funds holding JNJ

MTM Financial Group's JNJ Position: Q2 2026 in Review

MTM Financial Group reduced its Johnson & Johnson (JNJ) stake by 0.58% in Q2 2026, selling an estimated $3.26K and leaving 2,394 shares worth $608K. The position accounts for 0.26% of the portfolio, ranked #52.

MTM Financial Group first reported a position in JNJ in Q1 2022 and has held it in 18 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • MTM Financial Group held 2,394 shares of Johnson & Johnson worth $608K as of Q2 2026.
  • MTM Financial Group sold 14 Johnson & Johnson shares in Q2 2026, an estimated $3.26K.
  • Johnson & Johnson made up 0.26% of MTM Financial Group's portfolio in Q2 2026, its #52 holding.
  • MTM Financial Group first reported a position in Johnson & Johnson in Q1 2022 and has held it in 18 quarters since.
  • 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on MTM Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.